Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134789) titled 'A Prospective, Open-Label, Multicenter Clinical Study of Venetoclax Combined with All-Trans Retinoic Acid for Induction Therapy in Newly Diagnosed Acute Promyelocytic Leukemia' on Oct. 20.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Second Affiliated Hospital of Army Medical University
Condition:
Acute Promyelocytic Leukemia
Intervention:
VEN+ATRA:1. WBC=4*10^9/L, VEN 100mg,PO, qd, tillWBC<4*10^9/L
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-27
Target Sample Size: VEN+ATRA:60;
Countries of Recruitment:
China
To know more, visit https:/...